Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15141 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Mohammad Abumayyaleh und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidel…. Hauptthemen laut MEDLINE: Body Mass Index, Electric Countershock, Heart Failure, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter-defibrillator (WCD) remains underexplored.
Methods
In a multicentre international registry, we retrospectively collected data from a consecutive series of 1003 patients. These patients were divided into three body mass index (BMI) groups: <25 kg/m2 (n = 348), 25–30 kg/m2 (n = 383), and >30 kg/m2 (n = 272), with BMI > 30 kg/m2 defined as the reference category. Demographics, indications, adherence, WCD shocks, arrhythmic events, rehospitalization due to cardiovascular causes, and mortality were analysed.
Results
At 3 month follow-up, patients with a BMI > 30 showed the greatest improvement in left ventricular ejection fraction (LVEF) at 51.4%, significantly higher than the 41.4% in those with a BMI < 25 (P = 0.017) and comparable with the 49.4% in the BMI 25–30 group (P = 0.635). WCD wearing time and adherence were similar across all BMI groups. The incidence of WCD shock was similar across BMI groups. Rates of ventricular tachycardia (VT), ventricular fibrillation and non-sustained VT (ns-VT) were comparable across BMI groups. The rate of implantable cardioverter-defibrillator (ICD) implantation was 40.3% across all patients, with a slightly lower rate in the BMI > 30 group (36.8%) compared with others, although not significantly. Rehospitalization due to cardiovascular causes was significantly lower in the BMI > 30 group (55.4%) compared with the BMI 25–30 group (70.9%; P = 0.048), but similar to the BMI < 25 group (54.9%; P = 0.957). At 2 year follow-up, mortality was lower in the BMI > 30 group (5.9%) compared with the BMI < 25 (7.5%; P = 0.029) and BMI 25–30 groups (7%; P = 0.681). In multivariable analysis, LVEF at long term was significantly associated with a reduction in mortality.
Conclusions
Obese patients exhibited significantly greater improvement in LVEF, which was associated with reduced mortality. Adherence to WCD therapy was excellent across all BMI groups. ICD implantation occurred in 40.3% of patients, with similar WCD shock rates and arrhythmic events across BMI groups. An obesity paradox was observed, with obese patients demonstrating significantly lower rehospitalization rates due to cardiovascular causes and reduced mortality at follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
- European Center for AngioScience (ECAS) and DZHK (German Center for Cardiovascular Research (DZHK)), Partner Site, Heidelberg/Mannheim, Mannheim, Germany.
- Department of Cardiology and Angiology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany.
- Department of Cardiology/Division of Clinical Electrophysiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
- Department of Arrhythmias and Invasive Cardiology, St. Georg Hospital, Leipzig, Germany.
- Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Mohammad Abumayyaleh
Zitieren
APA
Abumayyaleh, M., Koepsel, K., Erath, J. W., Kuntz, T., Klein, N., Kovacs, B., Duru, F., Saguner, A. M., Blockhaus, C., Shin, D. I., Kreimer, F., Gotzmann, M., Lapp, H., Beiert, T., Aweimer, A., Mügge, A., Weiß, C., El-Battrawy, I., & Akin, I. (2025). Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator. ESC Heart Failure. https://doi.org/10.1002/ehf2.15141
Vancouver
Abumayyaleh M, Koepsel K, Erath JW, Kuntz T, Klein N, Kovacs B, et al. Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator. ESC Heart Failure. 2025. doi:10.1002/ehf2.15141
BibTeX
@article{Abumayyaleh2025,
author = {Abumayyaleh, Mohammad and Koepsel, Katharina and Erath, Julia W and Kuntz, Thomas and Klein, Norbert and Kovacs, Boldizsar and Duru, Firat and Saguner, Ardan M and Blockhaus, Christian and Shin, Dong-In and Kreimer, Fabienne and Gotzmann, Michael and Lapp, Hendrik and Beiert, Thomas and Aweimer, Assem and Mügge, Andreas and Weiß, Christel and El-Battrawy, Ibrahim and Akin, Ibrahim},
title = {Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15141}
}
EUVIMED